Edithistory:Inavolisib
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1069200317 | 2022-02-01T03:23:53Z | Rusalkii | Declining submission: nn - Submission is about a topic not yet shown to meet general notability guidelines (be more specific if possible) ([[WP:AFCH|AFCH]] 0.9.1) |
| 1069200252 | 2022-02-01T03:23:28Z | Rusalkii | |
| 1069200176 | 2022-02-01T03:22:58Z | Rusalkii | Reverted edits by [[Special:Contribs/Rusalkii|Rusalkii]] ([[User talk:Rusalkii|talk]]) to last version by Xtallographer |
| 1069200136 | 2022-02-01T03:22:43Z | Rusalkii | clean up ([[User:Novem Linguae/Scripts/DraftCleaner.js|DraftCleaner]]) |
| 1069179861 | 2022-02-01T00:51:05Z | Xtallographer | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1069179471 | 2022-02-01T00:48:11Z | Xtallographer | Created initial page for "inavolisib", an experimental PI3K inhibitor currently in clinical trials for PIK3CA-mutated cancers |
